Vol 12, No 2 (February 28, 2023): Translational Lung Cancer Research

Editorial

Understanding KRAS for better targeting
Ronak Patel, Jorge Nieva
Surgical series in mesothelioma: navigating between biases
Jo Raskin, Paul E. Van Schil, Jan P. Van Meerbeeck
Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma
Kevin Branch, Prasad S. Adusumilli, Marjorie G. Zauderer
Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma
Moshe Lapidot, Raphael Bueno
Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
Akifumi Nakamura, Kozo Kuribayashi
Spare the lung: surgical treatment approach for malignant pleural mesothelioma
Nobukazu Fujimoto
Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
Marc G. Denis, Guillaume Herbreteau, Elvire Pons-Tostivint
Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy?
Georg Schlachtenberger, Khosro Hekmat, Thorsten Wahlers, Matthias B. Heldwein

Original Article

Supervision by an experienced surgeon can reduce the learning curve of uniportal thoracoscopic lobectomy
Hitoshi Igai, Natsumi Matsuura, Kazuki Numajiri, Fumi Ohsawa, Mitsuhiro Kamiyoshihara
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations
Haowei Wang, Lei Cheng, Chao Zhao, Fei Zhou, Tao Jiang, Haoyue Guo, Jinpeng Shi, Peixin Chen, Zhuoran Tang, Shiqi Mao, Keyi Jia, Lingyun Ye, Chenlei Cai, Xuefei Li, Xiaoxia Chen, Caicun Zhou
A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
Xinyi Wang, Hui Jing, Hecheng Li
Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
Fernando Rodríguez-Cano, Virginia Calvo, Yago Garitaonaindía, José Luis Campo-Cañaveral de la Cruz, Mariola Blanco, María Torrente, Mariano Provencio
Peripheral T-cell receptor repertoire dynamics in small cell lung cancer
Meridith L. Balbach, Margaret L. Axelrod, Justin M. Balko, Armand Bankhead, Tristan Shaffer, Lee Lim, Jiannan Guo, Jennifer Hernandez, Mark Li, Wade T. Iams
Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)
Emmanuelle Renaud, Charles Ricordel, Romain Corre, Guillaume Leveiller, Florence Gadby, Hélène Babey, Josselin Annic, François Lucia, Vincent Bourbonne, Gilles Robinet, Renaud Descourt, Charles Orione, Gilles Quéré, Margaux Geier
Integrated analysis reveals the microenvironment of non-small cell lung cancer and a macrophage-related prognostic model
Shenglong Xie, Guixiang Huang, Weiwei Qian, Xuyang Wang, Hanlu Zhang, Zhiyang Li, Yu Liu, Yun Wang, Hongtao Yu
Integrative genomic profiling reveals characteristics of lymph node metastasis in small cell lung cancer
Kangle Kong, Shan Hu, Jiaqi Yue, Ziheng Yang, Salma K. Jabbour, Yu Deng, Bo Zhao, Fan Li
Differential organ-specific tumor response to first-line immune checkpoint inhibitor therapy in non-small cell lung cancer—a retrospective cohort study
Qi Wang, Yujia Fang, Chunyu Li, Tracy L. Leong, Mariano Provencio, In-Jae Oh, Zhemin Zhang, Chunxia Su